Ebina, Teresita P.

HRN: 21-84-86  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/10/2023
CEFTAZIDIME 1GM (VIAL)
09/10/2023
09/17/2023
IV
1gm
TID
CAP MR
Checking Final Appropriateness 

Indication:  Empirical Escalation    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: